Results 61 to 70 of about 395,223 (154)

Efficacy and safety of atypical antipsychotic drugs (quetiapine, risperidone, aripiprazole and paliperidone) compared with placebo or typical antipsychotic drugs for treating refractory schizophrenia: overview of systematic reviews

São Paulo Medical Journal
CONTEXT AND OBJECTIVE: According to some cohort studies, the prevalence of refractory schizophrenia (RS) is 20-40%. Our aim was to evaluate the effectiveness and safety of aripiprazole, paliperidone, quetiapine and risperidone for treating RS.
Tamara Melnik, Bernardo Garcia Soares, Maria Eduarda dos Santos Puga, Álvaro Nagib Atallah   +3 more
doaj   +1 more source

Risk factors for pneumonia in patients with schizophrenia

Neuropsychopharmacology Reports, 2018
Aim Pneumonia is a major cause of death in patients with schizophrenia. Preventive strategies based on identifying the risk factors are needed to reduce pneumonia‐related mortality.
Takahiro Haga, Kae Ito, Kentaro Sakashita, Mari Iguchi, Masahiro Ono, Koichiro Tatsumi   +5 more
doaj   +1 more source

A quantitative analysis of antipsychotic prescribing trends for the treatment of schizophrenia in England and Wales

JRSM Open, 2018
Objective This study aims to assess the current antipsychotic prescribing trends for the treatment of schizophrenia and to compare them with available guidelines and research evidence. Design An observational retrospective quantitative analysis.
Rossela Roberts, Abigail Neasham, Chania Lambrinudi, Afshan Khan   +3 more
doaj   +1 more source

Which atypical antipsychotic? [PDF]

British Journal of Psychiatry, 1998
C S, Thomas, S, Lewis
openaire   +2 more sources

The risk of bone fracture after long-term risperidone exposure is not increased compared to other atypical antipsychotics: A retrospective cohort study.

PLoS ONE, 2019
ObjectiveAntipsychotic agents can increase circulating serum prolactin levels, potentially leading to osteoporosis and increased risk of bone fracture. The risk appears to be lower for atypical antipsychotics.
Shih-Pei Shen, Yanfang Liu, Hong Qiu, Kuan-Yi Tsai, Hung-Chi Wu, Wen-Miin Liang, Meng Shu, Frank Huang-Chih Chou   +7 more
doaj   +1 more source

Seeing beyond the norm: Unveiling ocular complications with atypical antipsychotics

Industrial Psychiatry Journal
Psychotropic medications, particularly antipsychotics, are known to elicit various adverse effects, with ocular complications being underreported yet significant. This case series presents three instances where atypical antipsychotics, namely Risperidone,
Akansha Bhardwaj, Adarsh Bhardwaj, Bhumika, Ashu Sirowa   +3 more
doaj   +1 more source

Interaction Between Atypical Antipsychotics and the Gut Microbiome in a Bipolar Disease Cohort

Pharmacotherapy, 2017
Stephanie A. Flowers, S. Evans, Kristen M. Ward, M. McInnis, V. Ellingrod   +4 more
semanticscholar   +1 more source

Benefits and harms of atypical antipsychotics for agitation in adults with dementia.

European Neuropsychopharmacology, 2017
M. Farlow, T. Shamliyan
semanticscholar   +1 more source

Barriers to long‐acting injectable atypical antipsychotic use in Japan: Insights from a comparative psychiatrist survey

Neuropsychopharmacology Reports
Aims To investigate the negative attitudes of Japanese psychiatrists toward atypical long‐acting injectable (LAI) antipsychotics, which are the current mainstream LAIs in Japan.
Yoshiyo Oguchi, Nobumi Miyake, Kumiko Ando   +2 more
doaj   +1 more source

Lipid profile in schizophrenic patients on atypical antipsychotics

Gomal Journal of Medical Sciences, 2012
Background: Atypical antipsychotics are the drugs of first line treatment in schizophrenia because compared to typical antipsychotics, they have minimum extrapyramidal side effects and hence better tolerance by the patients resulting in better compliance.
Faiz ur Rahman, Ahmad Rafiq, Muhammad Shimal Khan, Arshad Parvez   +3 more
doaj